Certified by Founder Lodge
Avisi Technologies
United States - Redwood City, CA
START UP
1 Disclosed Funding Rounds $10,700,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Avisi is developing a portfolio of ophthalmic treatments based on a novel metamaterial technology. Its flagship product, VisiPlate, is a nanotechnology-enabled implant to treat glaucoma.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 26 ,2026 | Series A | $10,700,000 |
Golden Seeds
Good Growth Capital
Accanto Partners
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
Elly | $8,000,000 | (Feb 26, 2026)
Quill Meetings | $6,500,000 | (Feb 26, 2026)
Abram Scientific | $11,750,000 | (Feb 26, 2026)
Cicada | $13,500,000 | (Feb 26, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)
